Edition:
United Kingdom

Patricia Weiss

Großbritannien lässt als weltweit erstes Land Biontech-Impfstoff zu

02 Dec 2020

Frankfurt/London Großbritannien hat noch vor den USA und der EU als weltweit erstes Land den Corona-Impfstoff von BioNTech und Pfizer zugelassen.

BioNTech beantragt Zulassung von Corona-Impfstoff in Europa

01 Dec 2020

Frankfurt Die Hoffnungen auf den Einsatz eines Impfstoffs gegen das Coronavirus noch im Dezember steigen.

BioNTech says vaccine approval possible in mid-December under ideal conditions

19 Nov 2020

FRANKFURT U.S. and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of positive trial results. | Video

Corona-Impfstoff von BioNTech vor Zulassungsantrag

18 Nov 2020

Frankfurt Die Mainzer Biotechfirma BioNTech und ihr Partner Pfizer haben die entscheidende Hürde für eine mögliche Zulassung ihres Corona-Impfstoffs in den USA genommen.

"Wir können Covid-19 stoppen" - Moderna-Impfstoff gibt Hoffnung

16 Nov 2020

Frankfurt/New York Ein weiterer Studienerfolg mit einem Corona-Impfstoff schürt Hoffnungen im Wettlauf zur Beendigung der Pandemie.

Verteilung von Corona-Impfstoff stellt Logistik vor Mammut-Aufgabe

10 Nov 2020

Berlin/Frankfurt Bundesregierung und Unternehmen bereiten sich fieberhaft auf eine schnelle Verteilung des möglicherweise ersten Impfstoffs gegen das Coronavirus vor.

Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'

10 Nov 2020

FRANKFURT Positive data on BioNTech and U.S. partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.

Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'

10 Nov 2020

FRANKFURT Positive data on BioNTech and U.S. partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.

Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'

09 Nov 2020

FRANKFURT Positive data on BioNTech and U.S. partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.

BioNTech hopes COVID-19 vaccine will immunize for at least a year

09 Nov 2020

FRANKFURT BioNTech's co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer , would last for at least a year.

World News

PM Johnson and EU chief seek to break Brexit impasse

British Prime Minister Boris Johnson will speak to European Commission President Ursula von der Leyen on Saturday to try to break an impasse in trade talks with time running out to avoid a chaotic end to the Brexit saga.